par Takimoto, Chris H; Awada, Ahmad Liste de publications
Référence Cancer chemotherapy and pharmacology, 61, 4, (page 535-548)
Publication Publié, 2008-04
Article révisé par les pairs
Titre :
  • Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials.
Auteur : Takimoto, Chris H ; Awada, Ahmad
Informations sur la publication : Cancer chemotherapy and pharmacology, 61, 4, (page 535-548)
Statut de publication : Publié, 2008-04
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Chemotherapy
Combination
Phase I/II clinical trials
Solid tumors
Sorafenib
Targeted agent
Mots-clés MeSH : Animals
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- pharmacokinetics
Antineoplastic Agents -- pharmacology
Antineoplastic Agents -- toxicity
Antineoplastic Combined Chemotherapy Protocols -- pharmacology
Antineoplastic Combined Chemotherapy Protocols -- toxicity
Benzenesulfonates -- adverse effects
Benzenesulfonates -- pharmacokinetics
Benzenesulfonates -- pharmacology
Benzenesulfonates -- toxicity
Clinical Trials as Topic
Drug Interactions
Humans
Neoplasms -- drug therapy
Pyridines -- adverse effects
Pyridines -- pharmacokinetics
Pyridines -- pharmacology
Pyridines -- toxicity
Note : Journal Article
Review
Langue :
  • Anglais
Identificateurs : urn:issn:0344-5704 
info:doi/10.1007/s00280-007-0639-9
info:pmid/18026728